Loading clinical trials...
Loading clinical trials...
International Registry on the Use of the Direct Oral Anticoagulants for the Treatment of Unusual Site Venous Thromboembolism
Conditions
Interventions
Direct Oral Anticoagulants
Locations
24
United States
Henry Ford Health System
Detroit, Michigan, United States
Ottawa Hospital Research Institute
Ottawa, Canada
CHU Amiens Picardie
Amiens, France
Hôpital de la Cavale Blanche
Brest, France
Hôpital Edouard Herriot
Lyon, France
Hopital Louis Mourier
Paris, France
Start Date
October 1, 2019
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
July 3, 2025
NCT05021198
NCT06390475
NCT04994158
NCT03080883
NCT05448248
Lead Sponsor
University of Malta
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions